JPH11504035A - 糖により安定化されたガラス相の組成物 - Google Patents
糖により安定化されたガラス相の組成物Info
- Publication number
- JPH11504035A JPH11504035A JP8532283A JP53228396A JPH11504035A JP H11504035 A JPH11504035 A JP H11504035A JP 8532283 A JP8532283 A JP 8532283A JP 53228396 A JP53228396 A JP 53228396A JP H11504035 A JPH11504035 A JP H11504035A
- Authority
- JP
- Japan
- Prior art keywords
- amorphous
- composition
- sugar
- water
- amorphous phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Glass Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 結晶質水和物として存在することの可能な糖の使用であって、非晶質形 態の水溶性または水膨潤性物質を含有しかつ湿気も含有する非晶質過冷却相を有 する組成物における、該非晶質相をそれからの結晶化により脱水してそれにより 残留非晶質相のガラス転移温度を高めるための薬剤としての上記使用。 2. 組成物が、糖の水溶液を過飽和状態まで乾燥することにより得られる、 請求の範囲第1項に記載の使用。 3. 組成物中の糖対水の比率が結晶質水和物中の糖対水の比率より大きい、 請求の範囲第1項または第2項に記載の使用。 4. 残留非晶質相が少なくとも30℃のガラス転移温度を有する、請求の範 囲第1項、第2項または第3項に記載の使用。 5. 組成物の非晶質相が、酵素、他の蛋白質、ヌクレオシド、ヌクレオチド 、ジヌクレオチド、オリゴヌクレオチド、酵素補因子、非晶質合成有機化学薬品 および生物学的細胞から選択された物質を含有する、前記請求の範囲のいずれか 一項に記載の使用。 6. 非晶質形態の水溶性または水膨潤性物質からなる非晶 質過冷却相を含有する組成物であって、該非晶質相が少なくとも30℃のガラス 転移温度を有し、該非晶質相が結晶質糖水和物と一緒に存在し、しかも組成物の 総水分に関して該糖の量は非晶質相の重量百分率として表された非晶質相の水分 (もしあるなら)が組成物の重量百分率として表された組成物の総水分よりも小 さい百分率となるような量である上記組成物。 7. 非晶質相が非晶質形態の水溶性物質を含有し、かつ糖水和物の結晶が非 晶質相中に埋められている、請求の範囲第6項に記載の組成物。 8. 非晶質相が、結晶質糖水和物におけるのと同じ糖である非晶質糖からな る、請求の範囲第6項または第7項に記載の組成物。 9. 組成物の非晶質相が、炭水化物、ポリヒドロキシ化合物および合成ポリ マーから選択されかつ10℃ないし50℃の範囲の温度において安定な結晶質水 和物を形成しない水溶性または水膨潤性物質を含有する、請求の範囲第6項から 第8項のいずれか一項に記載の組成物。 10. 組成物の非晶質相が、酵素、他の蛋白質、ヌクレオシド、ヌクレオチ ド、ジヌクレオチド、オリゴヌクレオチド、 酵素補因子、生物学的細胞および非晶質合成有機化学薬品から選択された物質を 含有する、請求の範囲第6項から第9項のいずれか一項に記載の組成物。 11. 非晶質形態の水溶性または水膨潤性物質からなる非晶質過冷却相であ ってしかも少なくとも30℃のガラス転移温度を有する該非晶質相を含有する組 成物を製造する方法であって、結晶質水和物として存在することの可能な糖の水 溶液を乾燥して過飽和非晶質組成物を形成させ、そして残留非晶質相が残される ように該糖を該過飽和組成物から結晶質水和物として結晶化させる工程からなり 、しかも乾燥後の組成物の総水分に関して該糖の量は残留非晶質相の重量百分率 として表された残留非晶質相の水分(もしあるなら)が組成物の重量百分率とし て表された組成物の総水分よりも小さい百分率となるような量である上記方法。 12. 組成物を湿気に暴露して貯蔵するかまたは取り扱う工程を含み、かつ 糖水和物の結晶化がこの貯蔵または取扱い中吸収された水を捕縛する、請求の範 囲第12項に記載の方法。 13. 水溶液の乾燥が、80℃ないし300℃の範囲の温度にある熱ガス流 中に該溶液を噴霧し、該溶液をそれらが該ガ ス流中を移動している間に乾燥して粒子にし、これらの粒子をガス流から分離し そしてこれらの粒子を集めることにより行われる、請求の範囲第12項または第 13項に記載の方法。 14. 溶液の乾燥が30℃より低いガラス転移温度を有する過飽和非晶質組 成物を形成させ、その後それからの糖水和物の結晶化が非晶質相のガラス転移温 度を30℃より高い温度に上昇させる、請求の範囲第12項から第14項のいず れか一項に記載の方法。 15. 過飽和非晶質組成物を糖水和物の結晶化を誘発させる手段と接触させ る工程を含む、請求の範囲第12項から第15項のいずれか一項に記載の方法。 16. 残留非晶質相が、結晶質糖水和物におけるのと同じ糖である非晶質糖 からなる、請求の範囲第12項から第16項のいずれか一項に記載の方法。 17. 溶液および溶液の乾燥により形成された非晶質相が、酵素、他の蛋白 質、ヌクレオシド、ヌクレオチド、ジヌクレオチド、オリゴヌクレオチド、生物 学的細胞および非晶質合成有機化学薬品から成る群から選択された物質を含有す る、請求の範囲第12項から第17項のいずれか一項に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9508691.4 | 1995-04-28 | ||
GBGB9508691.4A GB9508691D0 (en) | 1995-04-28 | 1995-04-28 | Stable compositions |
PCT/GB1996/001014 WO1996033744A2 (en) | 1995-04-28 | 1996-04-26 | Compositions in glassy phase, stabilised by a sugar |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11504035A true JPH11504035A (ja) | 1999-04-06 |
Family
ID=10773701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8532283A Ceased JPH11504035A (ja) | 1995-04-28 | 1996-04-26 | 糖により安定化されたガラス相の組成物 |
Country Status (7)
Country | Link |
---|---|
US (2) | US6071428A (ja) |
EP (1) | EP0836483A2 (ja) |
JP (1) | JPH11504035A (ja) |
AU (1) | AU710039B2 (ja) |
CA (1) | CA2218929C (ja) |
GB (1) | GB9508691D0 (ja) |
WO (1) | WO1996033744A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008129937A1 (ja) * | 2007-04-13 | 2008-10-30 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 口腔用多層構造物とその製造方法 |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU659645B2 (en) * | 1991-06-26 | 1995-05-25 | Inhale Therapeutic Systems | Storage of materials |
US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US6673335B1 (en) * | 1992-07-08 | 2004-01-06 | Nektar Therapeutics | Compositions and methods for the pulmonary delivery of aerosolized medicaments |
DK0679088T3 (da) * | 1992-09-29 | 2002-10-28 | Inhale Therapeutic Syst | Pulmonal levering af aktive fragmenter af parathyreoideaea hormon |
US20030113273A1 (en) * | 1996-06-17 | 2003-06-19 | Patton John S. | Methods and compositions for pulmonary delivery of insulin |
AU689217B2 (en) * | 1994-03-07 | 1998-03-26 | Novartis Ag | Methods and compositions for pulmonary delivery of insulin |
ATE299892T1 (de) * | 1994-05-18 | 2005-08-15 | Nektar Therapeutics | Methoden und zusammensetzungen für die trockenpuderarznei aus interferonen |
US6290991B1 (en) * | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
US6258341B1 (en) | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
US6309671B1 (en) | 1995-04-14 | 2001-10-30 | Inhale Therapeutic Systems | Stable glassy state powder formulations |
GB9705588D0 (en) * | 1997-03-18 | 1997-05-07 | Anglia Research Foundation | Stable particle in liquid formulations |
US20030035778A1 (en) * | 1997-07-14 | 2003-02-20 | Robert Platz | Methods and compositions for the dry powder formulation of interferon |
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US6309623B1 (en) * | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
GB9726343D0 (en) * | 1997-12-13 | 1998-02-11 | Auffret Anthony | The use of excipients to accelerate freeze-drying |
US6234167B1 (en) * | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
ATE555773T1 (de) | 1999-06-09 | 2012-05-15 | Sievers Robert E | Überkritische fluidgestützte verneblung und blasen trochnen |
MY136453A (en) * | 2000-04-27 | 2008-10-31 | Philip Morris Usa Inc | "improved method and apparatus for generating an aerosol" |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
TWI290473B (en) | 2000-05-10 | 2007-12-01 | Alliance Pharma | Phospholipid-based powders for drug delivery |
WO2002009674A2 (en) * | 2000-07-28 | 2002-02-07 | Inhale Therapeutic Systems, Inc. | Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds |
US20090004240A1 (en) * | 2000-08-11 | 2009-01-01 | Celonova Biosciences, Inc. | Implants with a phosphazene-containing coating |
US6681998B2 (en) | 2000-12-22 | 2004-01-27 | Chrysalis Technologies Incorporated | Aerosol generator having inductive heater and method of use thereof |
US6701921B2 (en) | 2000-12-22 | 2004-03-09 | Chrysalis Technologies Incorporated | Aerosol generator having heater in multilayered composite and method of use thereof |
US6491233B2 (en) | 2000-12-22 | 2002-12-10 | Chrysalis Technologies Incorporated | Vapor driven aerosol generator and method of use thereof |
US6799572B2 (en) * | 2000-12-22 | 2004-10-05 | Chrysalis Technologies Incorporated | Disposable aerosol generator system and methods for administering the aerosol |
US7077130B2 (en) * | 2000-12-22 | 2006-07-18 | Chrysalis Technologies Incorporated | Disposable inhaler system |
US6501052B2 (en) | 2000-12-22 | 2002-12-31 | Chrysalis Technologies Incorporated | Aerosol generator having multiple heating zones and methods of use thereof |
US7101693B2 (en) * | 2001-09-07 | 2006-09-05 | Brigham Young University | Plasticized hydrophilic glasses for improved stabilization of biological agents |
US6568390B2 (en) | 2001-09-21 | 2003-05-27 | Chrysalis Technologies Incorporated | Dual capillary fluid vaporizing device |
US6640050B2 (en) | 2001-09-21 | 2003-10-28 | Chrysalis Technologies Incorporated | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
US6681769B2 (en) | 2001-12-06 | 2004-01-27 | Crysalis Technologies Incorporated | Aerosol generator having a multiple path heater arrangement and method of use thereof |
US6804458B2 (en) | 2001-12-06 | 2004-10-12 | Chrysalis Technologies Incorporated | Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate |
MXPA04005865A (es) | 2001-12-19 | 2004-09-13 | Nektar Therapeutics | Suministro de aminoglucosidos a los pulmones. |
US6701922B2 (en) | 2001-12-20 | 2004-03-09 | Chrysalis Technologies Incorporated | Mouthpiece entrainment airflow control for aerosol generators |
US20080176209A1 (en) * | 2004-04-08 | 2008-07-24 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
US20060099567A1 (en) * | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
EP3167961A1 (en) | 2004-04-08 | 2017-05-17 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
US20060039985A1 (en) * | 2004-04-27 | 2006-02-23 | Bennett David B | Methotrexate compositions |
US20070031342A1 (en) * | 2005-06-22 | 2007-02-08 | Nektar Therapeutics | Sustained release microparticles for pulmonary delivery |
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
EP1973406B1 (en) | 2005-12-28 | 2014-03-12 | Advanced Bionutrition Corporation | A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form |
AU2007234612B2 (en) * | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
WO2008076975A1 (en) | 2006-12-18 | 2008-06-26 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
CN101801405A (zh) | 2007-08-07 | 2010-08-11 | 先进科技及再生医学有限责任公司 | 包含于酸性水溶液中的gdf-5的蛋白质配方 |
WO2009129101A1 (en) | 2008-04-14 | 2009-10-22 | Advanced Technologies And Regenerative Medicine, Llc | Liquid buffered gdf-5 formulations |
CA2986751A1 (en) | 2009-03-27 | 2010-09-30 | Intervet International B.V. | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
ES2643148T3 (es) | 2009-05-26 | 2017-11-21 | Advanced Bionutrition Corporation | Composición en polvo seco estable que comprende microorganismos biológicamente activos y/o materiales bioactivos y métodos de producción |
AU2010258715B2 (en) | 2009-06-12 | 2015-04-09 | Perkinelmer Health Sciences, Inc. | Rehydratable matrices for dry storage of TAQ polymerase in a microfluidic device |
JP5953229B2 (ja) | 2009-06-12 | 2016-07-20 | マイクロニクス, インコーポレイテッド | マイクロ流体デバイス内でオンボード試薬を脱水保存する組成物および方法 |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
BR112012018839B1 (pt) | 2010-01-28 | 2020-04-14 | Advanced Bionutrition Corp | composição vítrea seca compreendendo um material bioativo |
WO2012018639A2 (en) | 2010-07-26 | 2012-02-09 | Biomatrica, Inc. | Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
EP2598660B1 (en) | 2010-07-26 | 2017-03-15 | Biomatrica, INC. | Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
BR112013003244B1 (pt) | 2010-08-13 | 2018-07-17 | Advanced Bionutrition Corp | composição seca estabilizante para material biológico, seu método de preparação, e formulação de carreamento oral |
EP3249054A1 (en) | 2012-12-20 | 2017-11-29 | Biomatrica, INC. | Formulations and methods for stabilizing pcr reagents |
EP3154338B1 (en) | 2014-06-10 | 2020-01-29 | Biomatrica, INC. | Stabilization of thrombocytes at ambient temperatures |
PT3328215T (pt) | 2015-07-29 | 2021-08-03 | Advanced Bionutrition Corp | Composições probióticas estáveis secas para utilizações dietéticas especiais |
DK3344048T3 (da) * | 2015-09-01 | 2021-06-21 | Douwe Egberts Bv | Fremgangsmåde til fremstilling af mejeripulver |
US10568317B2 (en) | 2015-12-08 | 2020-02-25 | Biomatrica, Inc. | Reduction of erythrocyte sedimentation rate |
CA2986535A1 (en) * | 2017-10-18 | 2019-04-18 | Quanta Associates, L.P. | Systems and methods for drying and cleaning an aerial lift electrically insulated boom |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60244288A (ja) * | 1984-05-18 | 1985-12-04 | Ookura Seiyaku Kk | 安定なセラペプタ−ゼ粉末の製造方法 |
JPH04271785A (ja) * | 1991-02-28 | 1992-09-28 | Kao Corp | 酵素固形製剤及びその製造方法 |
WO1993023065A1 (en) * | 1992-05-11 | 1993-11-25 | Applied Research Systems Ars Holding N.V. | Pharmaceutical compositions containing il-6 |
JPH05508315A (ja) * | 1990-05-14 | 1993-11-25 | クアドラント ホールディングス ケンブリッジ リミテッド | 生物学的巨大分子物質及び他の有機化合物の安定化 |
WO1995000127A1 (en) * | 1993-06-24 | 1995-01-05 | Astra Aktiebolag | Therapeutic preparation for inhalation |
JPH0733666A (ja) * | 1993-07-27 | 1995-02-03 | Kyowa Hakko Kogyo Co Ltd | インドロカルバゾール誘導体の安定化法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1855591A (en) * | 1926-02-03 | 1932-04-26 | Wallerstein Co Inc | Invertase preparation and method of making the same |
US3300474A (en) * | 1964-02-12 | 1967-01-24 | Pharmacia Ab | Sucrose ether copolymerizates |
US4267703A (en) * | 1977-02-22 | 1981-05-19 | Groen Division - Dover Corporation | Method and apparatus for manufacturing crystalline food products |
DE2748132A1 (de) * | 1977-10-27 | 1979-05-03 | Behringwerke Ag | Stabilisator fuer polysaccharid |
EP0111216A3 (en) * | 1980-03-31 | 1985-01-16 | Takeda Chemical Industries, Ltd. | Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor |
DE3141498A1 (de) * | 1981-10-20 | 1983-04-28 | Bayer Ag, 5090 Leverkusen | Arzneimittel enthaltend kallikrein und verfahren zu seiner herstellung |
US4457916A (en) * | 1982-08-31 | 1984-07-03 | Asahi Kasei Kogyo Kabushiki Kaisha | Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same |
JPS6092299A (ja) * | 1983-10-25 | 1985-05-23 | Sanwa Kosan Kk | 粉末マルト−スの製造法 |
US4892745A (en) * | 1984-05-03 | 1990-01-09 | The Procter & Gamble Co. | Texture equilibration in cookies |
DK8502857A (ja) * | 1984-06-25 | 1985-12-26 | ||
GB8500698D0 (en) * | 1985-01-11 | 1985-02-13 | Unilever Plc | Preparation of reagents |
EP0229810B1 (en) * | 1985-07-09 | 1991-10-16 | Quadrant Bioresources Limited | Protection of proteins and the like |
DE3541186A1 (de) * | 1985-11-21 | 1987-05-27 | Boehringer Mannheim Gmbh | Wasserloesliche, stabilisierte peroxidasederivate, verfahren zu ihrer herstellung und verwendung zur bestimmung von wasserstoffperoxid |
GB8604983D0 (en) * | 1986-02-28 | 1986-04-09 | Biocompatibles Ltd | Protein preservation |
US4753816A (en) * | 1987-05-20 | 1988-06-28 | Nabisco Brands, Inc. | Fruit juice based hard candy |
JP2518646B2 (ja) * | 1987-05-29 | 1996-07-24 | 株式会社 林原生物化学研究所 | マルト−ス粉末の製造方法 |
US5023092A (en) * | 1988-06-16 | 1991-06-11 | Ici Americas Inc. | Mannitol having gamma sorbitol polymorph |
GB8826429D0 (en) * | 1988-11-11 | 1988-12-14 | Univ Leeds Ind Service Ltd | Enzyme stabilisation systems |
GB8903593D0 (en) * | 1989-02-16 | 1989-04-05 | Pafra Ltd | Storage of materials |
ES2087963T3 (es) * | 1990-10-12 | 1996-08-01 | Duphar Int Res | Lactulosa solida. |
AU659645B2 (en) * | 1991-06-26 | 1995-05-25 | Inhale Therapeutic Systems | Storage of materials |
EP0624190A4 (en) * | 1992-01-21 | 1995-04-19 | Cryopharm Corp | METHOD FOR FREEZING CELLS AND MATERIALS SIMILAR TO CELLS. |
US5549757A (en) * | 1994-06-10 | 1996-08-27 | Ingredient Technology Corporation | Process for recrystallizing sugar and product thereof |
CN1152670C (zh) * | 1994-08-04 | 2004-06-09 | 廓德伦特控股剑桥有限公司 | 用来控释掺混在其中的分子的固体给药***及其制法 |
-
1995
- 1995-04-28 GB GBGB9508691.4A patent/GB9508691D0/en active Pending
-
1996
- 1996-04-26 CA CA002218929A patent/CA2218929C/en not_active Expired - Fee Related
- 1996-04-26 US US08/638,479 patent/US6071428A/en not_active Expired - Fee Related
- 1996-04-26 AU AU55056/96A patent/AU710039B2/en not_active Ceased
- 1996-04-26 JP JP8532283A patent/JPH11504035A/ja not_active Ceased
- 1996-04-26 EP EP96912104A patent/EP0836483A2/en not_active Ceased
- 1996-04-26 WO PCT/GB1996/001014 patent/WO1996033744A2/en active Application Filing
-
2000
- 2000-05-22 US US09/576,167 patent/US6503411B1/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60244288A (ja) * | 1984-05-18 | 1985-12-04 | Ookura Seiyaku Kk | 安定なセラペプタ−ゼ粉末の製造方法 |
JPH05508315A (ja) * | 1990-05-14 | 1993-11-25 | クアドラント ホールディングス ケンブリッジ リミテッド | 生物学的巨大分子物質及び他の有機化合物の安定化 |
JPH04271785A (ja) * | 1991-02-28 | 1992-09-28 | Kao Corp | 酵素固形製剤及びその製造方法 |
WO1993023065A1 (en) * | 1992-05-11 | 1993-11-25 | Applied Research Systems Ars Holding N.V. | Pharmaceutical compositions containing il-6 |
WO1995000127A1 (en) * | 1993-06-24 | 1995-01-05 | Astra Aktiebolag | Therapeutic preparation for inhalation |
JPH0733666A (ja) * | 1993-07-27 | 1995-02-03 | Kyowa Hakko Kogyo Co Ltd | インドロカルバゾール誘導体の安定化法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008129937A1 (ja) * | 2007-04-13 | 2008-10-30 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 口腔用多層構造物とその製造方法 |
Also Published As
Publication number | Publication date |
---|---|
AU710039B2 (en) | 1999-09-09 |
WO1996033744A3 (en) | 1996-12-19 |
AU5505696A (en) | 1996-11-18 |
EP0836483A2 (en) | 1998-04-22 |
US6503411B1 (en) | 2003-01-07 |
WO1996033744A2 (en) | 1996-10-31 |
US6071428A (en) | 2000-06-06 |
CA2218929C (en) | 2008-12-30 |
CA2218929A1 (en) | 1996-10-31 |
GB9508691D0 (en) | 1995-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11504035A (ja) | 糖により安定化されたガラス相の組成物 | |
US6872357B1 (en) | Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying | |
JP3338081B2 (ja) | 物質の貯蔵 | |
KR100777349B1 (ko) | 민감한 생물학적 물질의 보존방법 | |
JP4889602B2 (ja) | 生物学的物質用の保存及び貯蔵媒体 | |
JP4502406B2 (ja) | 乾燥発泡ガラスマトリックス内に物質を安定に配合する方法及びそれによって得られた組成物 | |
CA2482448C (en) | Preservation of bioactive materials by freeze dried foam | |
US8617576B2 (en) | Preservation of bioactive materials by freeze dried foam | |
US7153472B1 (en) | Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers | |
EA004131B1 (ru) | Способ сохранения вирусов и микоплазмы | |
JPH02265984A (ja) | 物質の貯蔵 | |
CZ219497A3 (cs) | Stabilizovaný přípravek s rekombinantním faktorem VIII prostý albuminu s malým obsahem cukru | |
WO2001037804A2 (en) | Preservation and formulation of bioactive materials | |
JP2021106571A (ja) | 顆粒の製造方法及び顆粒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070116 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070319 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070514 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070711 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070904 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071114 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100209 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100430 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100614 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20100830 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101005 |